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Forty-five patients with chronic urticaria were studied 
to determine: (1) the histologic incidence of leukocyto-
clastic vasculitis and (2) the clinical, laboratory and 
immunopathologic parameters that characterized this 
patient group. By histopathologic examination a spec-
trum of changes were noted as 9 patients showed leu-
kocytoclastic vasculitis, 15 a dense perivascular infil-
trate of lymphocytes and eosinophils, and 21 only a 
sparse lymphocytic perivascular infiltrate. Both the vas-
culitis and the dense infiltrate groups had an increased 
incidence of circulating immune complexes, as detected 
by Clq binding and monoclonal rheumatoid factor inhi-
bition radioassays. Direct immunofluorescence showed 
blood vessel deposition of immunoglobulins, comple-
ment, and/or fibrin in 33% of the vasculitis group, 13% 
of the dense infiltrate group, and 9% of the sparse infil-
trate group. These studies suggest that a meaningful 
number of patients with chronic urticaria have histo-
logic and immunopathologic findings of vasculitis. 
Chronic urticaria is a reaction pattern in the skin that results 
from many different stimuli, both immunologic and nonimmu-
nologic. The typical histologic features of urticaria include 
dermal edema, vascular dilatation, and a sparse perivascular 
cellular infiltrate [1]. 
Vasculitis, like urticaria, is not a specific disease per se, but 
represents a reaction pattern in the skin caused by a wide 
variety of substances involving different pathogenic mecha-
nisms including deposition of immune complexes. The lesions 
of cutaneous vasculitis may be pleomorphic, but are usually 
represented by palpable purpura. Histologically, cutaneous nec-
rotizing vasculitis is characterized by the following: (1) Endo-
thelial cell swelling of the blood vessels (venules), (2) perivas-
cular leukocytic infiltrate usually rich in neutrophils, (3) ex-
travasation of red blood cells, (4) fibrinoid deposits in and 
around the venules, and (5) leukocytoclasis (fragmentation of 
the leukocytes with nuclear debris) [2-5]. Some authors state 
that the latter 2 criteria are most critical since they represent 
direct signs of vessel injury [ 4]. 
In the past few years, isolated cases have been reported in 
which the a bove 2 skin reaction patterns-urticaria and vas-
culitis-have overlapped [6-21]. These reports suggest that 
some patients may present clinically as urticaria which, by skin 
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biopsy, shows leukocytoclastic vasculitis. Some of these patients 
have displayed various laboratory and clinical abnormalities, 
including the following: Elevated sedimentation rate (ESR) , 
hypocomplementemia, circulating immune complexes, arthral-
gias, abdominal pain, fever, lymphadenopathy, and glomerulo-
nephritis. The purpose of our current study was to prospectively 
determine in a group of patients with chronic idiopathic urti-
caria: ( 1) The histologic incidence of leukocytoclastic vasculitis, 
and (2) the clinical, laboratory, and immunopathologic param-
eters characterizing this subgroup. 
MATERIALS AND METHODS 
This prospective study included 45 consecutive patients who pre-
sented with the diagnosis of chronic idiopathic urticaria. This disease 
was defin ed clinically as urticaria which had persisted for at least 6 
weeks on a daily basis and with no detectable underlying etiology. The 
group consisted of 30 women and 15 men ranging from 4 to 80 yr of age. 
Thirty-one of the patients were seen at the Milwaukee Medical Clinic, 
S.C. (a private practice, multispecialty medical clinic) and 14 patients 
were seen at the teaching hospitals of the Medical College of Wisconsin 
(Milwaukee County Medical Complex and Wood Veterans Administra-
t ion Medical Center). Twenty-three of the patients were referred to 
om study by practicing dermatologists or allergists in the communi ty. 
The remaining 22 patients were seen initially by us for evaluation of 
their problem. 
All patients were either on no medications or minimal antihistamine 
therapy for at least 48 hr prior to the initial laboratory and biopsy 
procedures. The following laborato ry studies were performed in all 
patients: CBC and differential count, platelet count, urinalysis, sedi-
mentation rate, blood chemistries (SMA-12) , VDRL, quantitative im-
munoglobulins (lgG , IgM, IgA, lgE) , ant inuclear antibodies, rheuma-
toid factor , cryoglobulins, cryofibrinogens, hepatit is B antigen, and 
tota l hemolytic complement. 
Circulating immune complexes were measured by 2 radioassays-the 
Clq binding and monoclonal rheumatoid factor (mRF) inhibit ion assays 
recent ly described in detail (23]. Briefly, sera for immune complex 
studies were sepru·ated fro m freshly clotted blood and kept frozen at 
-70°C un t il tested. The Clq binding assay was performed by the 
method of Nydegger et al (24), with modifications described by Tap-
peiner et al (25]. The mRF inhibition assay was performed by the 
method of Luthra et al (26). 
Punch biopsies were obtained from 2 different urticarial lesions 
which , by history, were of recent onset (less than 24 lu· old) . One biopsy 
specimen was fixed in 10% formalin solution, stained with hematoxylin 
and eosin, and examined by light microscopy. The second biopsy 
specimen was tested by direct immunofluorescent (IF) sta ining accord-
ing to established methods using monospecific fluorescein-la beled an-
tisera to IgG, IgM, lgA, C3, and fibrin (Meloy Laboratories, Inc., 
Springfield, VA) [27). 
RESULTS 
Histop athology 
Biopsies of lesions from 45 chronic urticaria patients led to 
the establishment of 3 histologic categories (Ta ble) . Twenty-
one patients (47%) were classified as a "sparse infiltrate" group 
(Fig la and 1b) . This group presented the typical textbook 
histologic features of urticaria including (1) dermal edema, (2) 
vascular dilatation of small cutaneous blood vessels, and (3) 
sparse perivascular cellular infil trate consisting primarily of 
lymphocytes and a few eosinophils. Except for vascular dilata-
tion, the blood vessels displayed no abnormal alterations. 
Fifteen patients (33%) were classified as a "dense infiltrate" 
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Clinical, laboratory, and immunopathologic findings in histologic 
subgroups of chronic urticaria patients 
Leukocytoclastic Dense Sparse 
vasculitis infil trate infiltrate 
(%) (%) (%) 
Patients 20 33 47 
Posit ive direct IF of blood 33 13 9 
vessels 
Circulating immune com- 44 53 5 
plexes 
Clq assay 44 13 0 
mRF assay 22 47 5 
Individual lesions persisting 67 33 19 
>24 hr 
Elevated ESR 56 40 29 
Arthralgias 44 40 29 
Pressure urticaria 67 53 24 
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FIG 1. A , Sparse inftltrate group. Biopsy of urtica~ia l l esion showing 
sparse perivascular cellular infiltrate, consisting mostly of ly mphocytes 
and a few eosinophils (hematoxylin-eosin, reduced from x 160). B, Fig 
lA , reduced from X 400. 
group (Fig 2a and 2b). This group also demonstrated dermal 
edema and vascular dilatation but differed from the sparse 
infiltrate group in the amount and type of perivascular cellular 
inflltrate present. These patients had moderate to dense peri-
vascular infiltrates composed primarily of lymphocytes and 
eosinophils. Some patients had marked eosinophilic inflltrates 
with eosinophilic degranulation. None of the patients, however, 
had evidence of vasculitis as defined below. 
Nine patients (20%) were classified as a "leukocytoclastic 
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vasculitis" group (Fig 3a, 3b, and 3c). Each of these patients 
had to have at least leukocytoclasis (fragmentation of the 
leukocytes with nuclear debris) and/or fibrinoid deposits in and 
around the vessel walls. Each of the 9 patients had both 
leukocytoclasis and fibrinoid deposits present in varying de-
grees. These patients displayed a moderate to dense perivas-
cular cellular infiltrate usually rich in neutrophils but also 
containing lymphocytes and eosinophils. Extravasation of red 
blood cells was also occasionally present. 
Direct Immunofluorescence 
Direct IF of urticarial lesions revealed various combinations 
of immunoglobulins, complement and fibrin in the vessel walls 
of 16% of the patients (Fig 4). These patterns were typical of 
the vessel wall fluorescence seen in patients with cutaneous 
vasculitis. Positive immunofluorescence was found in 33% of 
the leukocytoclastic vasculitis group, 13% of the dense inftltrate 
group, and 9% of the sparse inflltrate group. Two of the patients 
in the leukocytoclastic vasculitis group also had dermal-epider-
mal junctional IF. 
Circulating Immune Complexes 
By the Clq binding and mRF inhibition radioassays, 44% of 
the leukocytoclastic vasculitis group had detectable circulating 
immune complexes, 44% by the Clq assay and 22% by the mRF 
~ 
FIG 2. A, Dense infiltrate group. Biopsy of l.O"ticariallesion shov!ing 
dense perivascular ce llula r inftltrate, composed mainly of lymphocytes 
and eosinophils (h ematoxylin-eosin, reduced from X 160). B , Fig 2A, 
reduced from X 400. 
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FIG 3. A, Leukocytoclastic vasculitis group. Biopsy of urticarial 
lesion showing dense perivascular ceUulru· infiltrate composed of neu-
trophils, lymphocytes, and eosinophils. Leukocytoclasis and fibrinoid 
deposits are present in and around the vessel walls (hematoxylin-eosin, 
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FIG 4. Direct IF of urticarial lesion demonstrating deposition of IgM 
in cutaneous blood vessels (reduced from x 500). 
assay (Fig 5). The dense infiltrate group (53%) had detectable 
circulating immune complexes, 13% by the Clq assay and 47% 
by the mRF assay. Only 5% of the sparse infiltrate group had 
detectable circulating immune complexes and these only with 
the mRF assay. 
Laboratory Studies 
The only frequently abnormal laboratory test was the eryth-
rocyte sedimentation rate (ESR) which was elevated in 56% of 
the leukocytoclastic vasculitis group, 40% of the dense infiltrate 
group, and 29% of the sparse infiltrate group. Patients (27%) 
had elevated IgE levels, but these were evenly distributed 
among the 3 groups. No other laboratory abnormalities were 
commonly found in any of the 3 groups by the several other 
tests performed. Of interest only one of the 45 patients had 
hypocomplementemia. This patient was subsequently diag-
nosed as having systemic lupus erythematosus. 
Signs and Symptoms 
The duration of individual urticarial lesions varied among 
the 3 histologic groups. Individual lesions persisted for more 
than 24 hr in 67% of the leukocytoclastic vasculitis group. Only 
33% of the dense infiltrate group and 19% of the sparse infiltrate 
group, however, had in'dividuallesions persisting for more than 
24 hr. Arthralgias were also more common in the leukocyto-
clastic vasculitis group (44%) and the dense inftltrate group 
(40%) when compared to the sparse infiltrate group (29%). 
Pressure urticaria (i.e., urticaria which, by history, was induced 
by physical pressure to the skin), was more common in leuko-
cytoclastic vasculitis group (67%) and the dense infiltrate group 
reduced fi·om X 160). B , Fig 3A, reduced from X 400. C, Biopsy of 
urt icarial lesion from a different patient showing leukocytoclast ic vas-
culi t is (hematoxylin-eosin, reduced from X 400). 
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LEUKOCYTOCLASTIC OENSE SPARSE 
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FIG 5. Scattergram demonstrating Clq (e) and MRF (0 ) reactivity 
in serum samples from patients with different histologic categories of 
chronic urticaria. Serum samples with normal levels of Clq and MRF 
reactive materials (:5 5 ug Agg IgG eq/ ml) are included in the hatched 
areas. 
(53%) than the sparse infiltrate group (24%). Angioedema was 
equally distributed among the 3 groups. Gastrointestinal pain 
was present in only one patient who was subsequently found to 
have shigellosis. Fever, lymphadenopathy, and glomerulone-
phritis were not present in any of the patients. 
DISCUSSION 
In the past few years, isolated case reports have appeared in 
the literature in which patients present with a clinical picture 
of urticaria which, when biopsied, shows ieukocytoclastic vas-
culitis rather than the usual histologic features of urticaria [6-
21]. The few studies reported to date are conflicting as to the 
incidence of vasculitis in typical chronic idiopathic urticaria. 
Phanuphak et al [22) recently presented 42 consecutive patients 
with chronic urticaria; 22 patients displayed vasculitis on bi-
opsy. Vasculitis in this study was defined by the presence of 
inflammatory cell inflltrates within the blood vessel wall. Syn-
kowski et ar[28] reported 14 randomly chosen patients with 
acute and chronic urtic~ria, but found no histologic evidence of 
vasculitis in any of their patients. 
In the present prospective study of 45 patients with chronic 
idiopathic urticaria, a spectrum of changes were apparent by 
histologic examination. Twenty percent of the patients dem-
onstrated a leukocytoclastic vasculitis. In order to be classified 
as leukocytoclastic vasculitis in our study, histologic evidence 
of leukocytoclasis and/or fibrinoid deposits in and around the 
vessel walls was required. In addition, a moderate to dense 
perivasc\}lar cell infiltrate, extravasation of red blood cells, and 
vascular endothelial cell swelling was apparent. Fifty percent of 
the patients demonstrated a dense perivascular inflltrate with 
or without evidence of vasculitis. The remaining 50% demon-
strated more typical histologic pictures of urticaria, including a 
sparse perivascular cellular infiltrate. 
Although no single serologic or immunopathologic parameter 
was characteristic of any of our histologic subgroups, certain 
patterns were clearly present. Both the leukocytoclastic vas-
culitis and dense inftltrate groups manifested an increased 
incidence of positive direct IF of blood vessels. Immunoglobu-
lins, complement, and fibrin deposition are frequently observed 
in lesions of vasculitis by direct IF [29-32]. Sixteen percent of 
the total group of patients and 33% of the vasculitis group had 
positive vessel wall IF typical of the pattern seen in leukocy-
toclastic vasculitis. 
Circulating immune complexes are frequently detected in 
leukocytoclastic vasculitis, and increasing evidence exists that 
Vol. 76, No.2 
the deposition of these immune complexes in blood vessel walls 
is involved in the pathogenesis [23, 33-38). In the isolated case 
reports of "urticarial vasculitis," circulating immune complexes 
were often detectable. In our series of chronic urticaria patients, 
44% of the vasculitis group and 53% of the dense inflltrate group 
had detectable circulating immune complexes. 
Hypocomplementemia was not a significant finding in our 
study. Only 1 of our 45 patients had depressed total comple-
ment, and this patient was subsequently found to have systemic 
lupus erythematosus. On the other hand, the vast majority of 
previously reported cases of "urticarial vasculitis" had de-
pressed complement levels. In these cases, although different 
complement components were depressed, the total hemolytic 
complement was always abnormal. Hypocomplementemia may 
be an important distinguishing parameter between urticarial 
vasculitis and typical chronic idiopathic urticaria associated 
with histologic evidence of leukocytoclastic vasculitis. 
The importance of an elevated ESR is noteworthy. In the 
majority of reported cases of "urticarial vasculitis," the ESR is 
elevated. In addition, some reports suggest that urticaria pa-
tients without evidence of necrotizing venulitis invariably have 
a normal ESR (39], a finding not supported by our study. 
Thirty-six percent of the total group of chronic urticaria pa-
tients had elevated ESRs. This finding was more common in 
the vasculitis group where 56% had elevated ESRs. Some of 
the patients with vasculitis histologically, however, had a nor-
mal ESR, while some with no evidence of vasculitis had an 
elevated ESR. Although a nonspecific test, the ESR is useful 
because its elevation should suggest further investigation of the 
possibility of an underlying vasculitis. A normal ESR, on the 
other hand, does not preclude an underlying vasculitis. 
Certain clinical signs and symptoms may also be useful in 
distinguishing the different histologic groups of chronic urti-
caria patients. Traditionally, individual urticariallesons persist 
for less than 24 hr. Sixty-seven percent of our vasculitis group 
had individual lesions which persisted for periods greater than 
24 hr. This finding is similar to the previously reported cases of 
"urticarial vasculitis" where individual lesions frequently per-
sisted for more than 24 hr, and occasionally resolved leaving 
purpuric changes. Arthralgias were present in approximately 
one-third of all our chronic urticaria patients, but were some-
what more common in the vasculitis group. Similar findings 
have been noted in previously reported cases of "urticarial 
vasculitis." Pressure urticaria was also a common clinical find-
ing in the vasculitis and dense infiltrate groups. Other systemic 
signs such as arthritis, fever, gastrointestinal pain, lymphade-
nopathy, and glomerulonephritis were occasionally noted in 
reported cases of "urticarial vasculitis". None of these latter 
fmdings were apparent in our group of urticaria patients. 
It is our contention that "urticarial vasculitis" is an entity 
requiring 2 features-a clinical picture of urticaria which, by 
skin biopsy, shows leukocytoclastic vasculitis. The probable 
underlying pathogenic mechanism in this condition is one of 
immune complex deposition. Possessing the above features are 
a heterogeneous group of patients displaying a spectrum of 
clinical, laboratory, and immunopathologic changes. The pa-
tients described in this study represent the less severely affected 
end of this spectrum. Our patients were chru·acterized by idio-
pathic chronic urticaria, minimal signs or symptoms of systemic 
disease except for frequent arthralgias, some serologic and 
immunopathologic findings suggestive of vasculitis, and normal 
complement levels. The isolated case reports of urticarial vas-
culitis [6-21] appearing under the names of "hypocomplemen-
temic vasculitis", "unusual SLE-related syndrome," or "urti-
caria with vasculitis" represent a more severely involved part 
of this spectrum. These patients often had features which 
distinguished them from the patients reported in our study. 
Some of these distinguishing features were the following: addi-
tional skin lesions which were purpuric or erythema multi-
forme-like; clinical signs or symptoms of multisystem disease 
such as arthralgias, arthritis, fever, gastrointestinal pain, lymph-
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ade nopathy, and glomerulonephritis; a higher incidence of se-
rologic and immunopathologic findings suggestive of vasculitis, 
and hypocompJementemia . Whether some of these patie n ts 
represent a subset of collagen-vascular disease remains to be 
determined. Finally, the most severe end of the spectrum of 
" urticarial vasculitis" is represented by those patients with 
systemic lupus eryth ematosus who present with urticarial-like 
lesions [ 40]. 
In summary, chronic urticaria patients show a spectrum of 
changes on histologic examination including leukocytoclastic 
vasculitis. In a ddition, a m eaningful number of these chronic 
urticaria patients show other serologic and immunopathologic 
find ings suggestive of vasculitis. In subdividing chronic urticaria 
patients by va rious criteria, including histopathology and IF, 
ow· understanding of the pathogenic m echanisms involved in 
this perplexing condition should improve. The findings of vas-
culitis and immune complex disease in some patients with 
chronic urticaria may improve our future ability to predict the 
course and to individualize treatment in t h ese patients. 
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